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Objectives 
A common nonsense polymorphism (R577X) in the ACTN3 (α-actinin-3 protein) has been 
associated with elite athlete status previously and, more specifically, the X-allele has been 
positively associated with elite endurance status. However, this remains inconclusive due to 
contradictory reports within the current literature. Thus, the current study aimed to compare 
ACTN3 R577X genotype and allele frequency distributions in ‘elite’ and ‘sub-elite’ marathon 
runners with those of a non-athletic, control population and to determine whether marathon 
personal best time was associated with ACTN3 R577X genotype. 
Method 
Four hundred and eighty four elite and sub-elite European Caucasian marathon runners and 
554 ethnically matched controls provided a DNA sample from which the ACTN3 R577X 
polymorphism was genotyped using real-time PCR. Personal best (PB) times were used to 
determine elite (men <2 h 30 min, n=111; women <3 h 00 min, n=105) or sub-elite (men 2 h 
30 min – 2 h 45 min, n=189; women 3 h 00 min – 3 h 15 min, n=79) status. Genotype and allele 
frequencies were compared between athletes and controls using Chi-square analyses. One-way 
ANOVAs were implemented to identify any genotype-dependent differences in PB times for 
men and women, which were subject to correction for multiple comparisons.  
Results 
The X allele was ~3% more frequent in the marathon runners than in non-athlete controls (see 
Table 1 and Figure 1), although this small difference did not approach statistical significance. 
There were no significant differences in genotype (χ2 = 3.40; P = 0.182) or allele (χ2 = 2.31; P 
= 0.128) frequency distributions between athletes (RR=29.1%, RX=50.6% XX=20.2%; 
R=54.4%, X=45.6%) and controls. There were also no differences between elite and sub-elite 
genotype (P = 0.968, χ2 = 0.66) and allele frequencies (P = 0.916, χ2 = 0.11). Similarly, no 
differences in genotype or allele frequencies were found between either elite (P = 0.439, χ2 = 
1.65; P = 0.265, χ2 = 1.24) or sub-elite (P = 0.254, χ2 = 2.74; P=0.183, χ2 = 1.772) runners and 
the control group. Neither were PB times genotype-dependent for either men (P = 0.864) or 
women (P = 0.966). 
Table 1: ACTN3 R577X polymorphism count, genotype and allele frequencies in elite, sub-
elite and control groups. 
 
Conclusion 
No differences in genotype and allele frequencies were observed between athletes and controls, 
elite vs sub-elite, nor elite and sub-elite comparisons with the control group. Additionally, there 
was no genotype-dependent influence on PB time, which further emphasises that the ACTN3 
R577X polymorphism does not influence elite endurance athlete status or determine marathon 
performance in European Caucasian runners. This is congruent with some previous findings 
and suggests other genetic variants or environmental factors may play a more prominent role 
in achieving elite endurance athlete status.   
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 Genotype count (%) Allele count (%) 
RR RX XX R X 
Elite (n=216) 64 (29.6) 108 (50.0) 44 (20.4) 236 (54.6) 196 (45.4) 
Sub-elite (n=268) 77 (28.7) 137 (51.1) 54 (20.1) 291 (54.3) 245 (45.7) 
Controls (n=554) 191 (34.5) 258 (46.6) 105 (19.0) 640 (57.8) 468 (42.2) 
